Cultural and intergenerational pathways between family alcohol use, trauma exposure, and probable PTSD in Taiwanese adolescents
Spectral EEG-guided adaptive neuromodulation for social anxiety disorder, performance-only subtype: a case report
Functional MRI evidence of brain alterations in premenstrual dysphoric disorder: a systematic review
Marked for destruction
Nature Biotechnology, Published online: 04 June 2026; doi:10.1038/s41587-026-03182-5
The significance of the first FDA-approved PROTAC lies not in proving that targeted protein degradation is superior to conventional therapies, but in proving that degrading proteins is possible as a therapeutic.
A socially assistive robot to support mental wellbeing in LGBTQ+ young people at risk of self-harm: a randomized controlled trial
Nature Medicine, Published online: 04 June 2026; doi:10.1038/s41591-026-04422-6
A randomized controlled trial integrating Purrble, a socially assistive tactile robot, into safety planning found that LGBTQ+ youth at risk of self-harm experienced improvements in Difficulties in Emotion Regulation Scale and fewer depressive symptoms compared to safety planning alone.
AAV gene therapy for homozygous familial hypercholesterolemia: a phase 1 trial
Nature Medicine, Published online: 04 June 2026; doi:10.1038/s41591-026-04441-3
After preclinical testing, a phase 1 trial involving three individuals with familial hypercholesterolemia demonstrated preliminary evidence for the safety and efficacy of AAV8-mediated LDL receptor gene therapy.
Spinal cord stimulation for upper limb motor function in people with chronic post-stroke hemiparesis: a feasibility trial
Nature Medicine, Published online: 04 June 2026; doi:10.1038/s41591-026-04435-1
In this feasibility clinical trial, the authors show that epidural stimulation of the cervical spinal cord safely improved strength, function and spasticity in seven people with arm hemiparesis.
Human microglial transitions at the Aβ–tau inflection point associate with divergent pathways to dementia and resilience
Nature Medicine, Published online: 04 June 2026; doi:10.1038/s41591-026-04393-8
Microglia cellular changes underlie divergent resilience-associated mechanisms in human aging.
Aberrant tau accumulation caused by MAPT mutations induces early pathological changes in axonal transport that are rescued by p38α inhibition
Nature Neuroscience, Published online: 04 June 2026; doi:10.1038/s41593-026-02266-4
Imaging axonal transport in vivo in the mouse cortex reveals that deficits in axonal transport arise at early stages of tau pathology, are caused by enlarged tau envelopes and are reversed by inhibiting MAPK p38α.

